Search results for "fertility"

showing 10 items of 629 documents

Day-3 embryo metabolomics in the spent culture media is altered in obese women undergoing in vitro fertilization

2015

Objective To determine whether the global metabolomic profile of the spent culture media (SCM) of day-3 embryos is different in obese and normoweight women undergoing in vitro fertilization (IVF). Design Prospective cohort analysis. Setting IVF clinic. Patient(s) Twenty-eight young, nonsmoking women with normoweight, nonsmoking male partners with mild/normal sperm factors undergoing a first IVF attempt for idiopathic infertility, tubal factor infertility, or failed ovulation induction: obese ovulatory women (n = 12); obese women with polycystic ovary syndrome (PCOS; n=4); normoweight ovulatory women (n = 12). Intervention(s) Fifty μl of SCM collected from two day-3 embryos of each cohort. M…

AdultMalemedicine.medical_specialtyProteomemedicine.medical_treatmentPhysiologyFertilization in VitroEmbryo Culture TechniquesHuman fertilizationInternal medicinemedicineHumansObesityProspective cohort studyIn vitro fertilisationbusiness.industryObstetrics and GynecologyEmbryoTubal factor infertilityEmbryo TransferEmbryo Mammalianmedicine.diseasePolycystic ovaryCulture MediaEndocrinologyGene Expression RegulationReproductive MedicineCohortMetabolomeFemaleOvulation inductionbusinessInfertility FemalePolycystic Ovary SyndromeFertility and Sterility
researchProduct

GnRH agonist administration at the time of implantation does not improve pregnancy outcome in intrauterine insemination cycles: a randomized controll…

2009

Objective To assess whether GnRH agonist administration in the luteal phase improves pregnancy outcome in intrauterine insemination (IUI) cycles. Design Single-center, randomized, single-blind, placebo-controlled trial. Setting University-affiliated infertility clinic, between February 2005 and December 2007. Patient(s) Three hundred forty-four women undergoing IUI owing to mild to moderate male factor or donor sperm indication. Intervention(s) Random administration to either a single subcutaneous injection of 0.1 mg triptorelin (group A; n = 172) 8 days after hCG administration, or solvent only (group B; n=172) at the same time. Main Outcome Measure(s) Pregnancy rate was the primary outcom…

AdultMalemedicine.medical_specialtyTime FactorsPregnancy Ratemedicine.medical_treatmentLuteal phaseDrug Administration Schedulelaw.inventionMiscarriageGonadotropin-Releasing HormonePlacebosRandomized controlled triallawPregnancyMedicineHumansSingle-Blind MethodEmbryo ImplantationInsemination ArtificialGynecologyPregnancyTriptorelin Pamoatebusiness.industryObstetricsArtificial inseminationUterusPregnancy OutcomeObstetrics and GynecologyFertility Agents Femalemedicine.diseaseTriptorelinPregnancy rateReproductive MedicineGestationFemalebusinessAlgorithmsmedicine.drugFertility and sterility
researchProduct

Systemic Treatment with Interferon-α2B: An Effective Method to Prevent Sterility after Bilateral Mumps Orchitis

1991

In men orchitis represents the most common complication of mumps infection and occurs in 5 to 37% of this population. Bilateral manifestation is observed in 16 to 65% of the patients. The most important danger is the risk of testicular atrophy which results in sterility. Four patients with bilateral mumps orchitis received systemic treatment with interferon-alpha 2B (3 x 10(6) IU per day) for 7 days. All acute symptoms of mumps orchitis disappeared within 2 to 4 days of hospitalization. During 6 to 15 months of followup no incidence of testicular atrophy was observed. In 3 of 4 patients pre-treatment examination revealed subfertility (oligoasthenospermia), while 2 to 4 months after interfer…

AdultMalemedicine.medical_specialtyUrologyPopulationAlpha interferonOrchitisInterferon alpha-2TestismedicineHumansProspective StudiesRadionuclide ImagingAdverse effecteducationMumpsInfertility MaleInterferon alfaAcetaminophenUltrasonographyeducation.field_of_studyPalpationTesticular atrophybusiness.industryInterferon-alphamedicine.diseaseRecombinant ProteinsSurgeryConcomitantDrug EvaluationOrchitisComplicationbusinessmedicine.drugJournal of Urology
researchProduct

Timing of cell division in human cleavage-stage embryos is linked with blastocyst formation and quality

2012

Noninvasive markers of embryo quality are being sought to improve IVF success. The present study aimed to discover possible associations between embryo division kinetics in the cleavage stage, the subsequent ability of human embryos to reach the blastocyst stage and the resulting blastocyst morphology. A retrospective cohort study analysed 834 embryos from 165 oocyte donation couples using a time-lapse monitoring system that allowed the recording of the exact timings for key events related to embryo development. Timing parameters were categorized into four quartiles. The probability of an embryo developing to a blastocyst was linked to a strict chronology of development. To further evaluate…

AdultMalemedicine.medical_specialtyanimal structuresAdolescentCell divisionBiologyModels BiologicalTime-Lapse ImagingCohort StudiesAndrologyYoung AdultEmbryo cryopreservationmedicineHumansSperm Injections IntracytoplasmicBlastocystEctogenesisreproductive and urinary physiologyRetrospective StudiesGynecologyOocyte DonationEmbryogenesisObstetrics and GynecologyEmbryoEmbryo TransferEmbryo MammalianEmbryo transferKineticsBlastocystmedicine.anatomical_structureReproductive Medicineembryonic structuresEctogenesisFemaleInfertility FemaleBiomarkersCell DivisionEmbryo qualityDevelopmental BiologyReproductive BioMedicine Online
researchProduct

Successful pregnancy and childbirth after intracytoplasmic sperm injection with calcium ionophore oocyte activation in a globozoospermic patient

2007

Objective To check the effectiveness of intracytoplasmic sperm injection (ICSI) combined with assisted oocyte activation (AOA) in a globozoospermic patient. Design Case report. Setting Instituto Valenciano de Infertilidad, Valencia, Spain. Patient(s) A patient with globozoospermia. Intervention(s) ICSI was administered in 14 oocytes. ICSI combined with AOA, in which a small amount of calcium was injected followed by calcium ionophore exposure, was done in 9 oocytes. Main Outcome Measure(s) Fertilization rate and embryo quality was assessed in both groups. Result(s) Chemical activation increased fertilization rate (55.6% vs. 35.7%) and the number of embryos with less multinucleation on day 2…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentIntracytoplasmic sperm injectionAndrologyHuman fertilizationPregnancyHumansMedicineSperm Injections IntracytoplasmicGlobozoospermiaAzoospermiaGynecologyAzoospermiaPregnancyIonophoresbusiness.industryFertility Agents MaleObstetrics and GynecologyOocyte activationEmbryomedicine.diseaseCombined Modality TherapyTreatment OutcomeReproductive Medicineembryonic structuresOocytesCalciumFemalebusinessLive BirthEmbryo qualityFertility and Sterility
researchProduct

The significance of sperm DNA oxidation in embryo development and reproductive outcome in an oocyte donation program: a new model to study a male inf…

2008

Objective: One byproduct resulting from free radical damage is the DNA hydroxylation also known as DNA oxidation. Our aim with this work was to determine the relevance of sperm DNA oxidation on embryo quality in oocyte donation cycles. Design: We prospectively studied pairs of oocyte donation cycles, i.e., the same oocyte donors, donating to two recipients, where the only difference between the two treatments was the use of a different sperm sample. Setting: University-affiliated private IVF setting. Patient(s): Infertile male partners from couples undergoing oocyte donation cycles (n=38): 76 semen aliquots analyzed before and after semen processing by swim up. Intervention(s): None. Main O…

AdultMalemedicine.medical_treatmentEmbryonic Developmentembryofree radicalsFertilization in VitroReproductive technologyBiologyspermmale fertilityMale infertilityAndrologyPregnancymedicineHumansProspective StudiesDNA oxidationInfertility MaleSperm motilityOocyte Donationurogenital systemArtificial inseminationPregnancy OutcomeDeoxyguanosineObstetrics and GynecologyEmbryoDNAMiddle AgedPrognosismedicine.diseaseOocyteSpermatozoaSpermmedicine.anatomical_structureReproductive Medicine8-Hydroxy-2'-Deoxyguanosineoocyte donationLinear ModelsFemaleOxidation-ReductionSperm CapacitationBiomarkersEmbryo qualityFertility and Sterility
researchProduct

Ovarian stimulation does not influence the uterine immune environment in healthy infertile women.

2019

Abstract Research question There is some controversy regarding the impact of ovarian stimulation on immune cells in women undergoing IVF. The study's aim was to determine whether ovarian stimulation affected immune uterine cells in healthy women undergoing IVF. Design This prospective cohort study included 28 patients undergoing IVF and 47 healthy oocyte donors. Endometrial biopsies were taken in a natural cycle and after ovarian stimulation. All participants had a normal karyotype, pelvic ultrasound and cervical cytology results and thyroid-stimulating hormone concentration, as well as normal glucose and insulin concentrations and inherited and acquired thrombophilia test results. Screenin…

AdultNecrosisendocrine system diseasesPopulationStimulationEndometrial biopsies Immune cell populations Natural cycles Ovarian stimulation Peripheral blood natural killer cells Uterine natural killer cellsHuman leukocyte antigenAndrologyImmune systemOvulation InductionmedicineHumansEmbryo ImplantationProspective Studieseducationreproductive and urinary physiologyMenstrual Cycleeducation.field_of_studybusiness.industryUterusObstetrics and GynecologyFOXP3biochemical phenomena metabolism and nutritionfemale genital diseases and pregnancy complicationsKiller Cells NaturalReproductive MedicinebacteriaTumor necrosis factor alphaFemalemedicine.symptombusinessInfertility FemaleDevelopmental BiologyHormoneReproductive biomedicine online
researchProduct

Does metformin induce ovulation in normoandrogenic anovulatory women?

2004

Objective: This study was undertaken to evaluate the efficacy of metformin in women with anovulation who do not have evidence for hyperandrogenism and classic polycystic ovary syndrome. Study design: A randomized trial of metformin (1500 mg daily) and placebo in 24 anovulatory women was undertaken for 3 months. Assessments of changes in hormone levels and insulin sensitivity were carried out. Abnormal ormonal values were defined by levels exceeding the range in normal ovulatory controls. Results: Anovulatory women had normal androgen levels and luteinizing hormone but had higher serum insulin and lower insulin sensitivity compared with controls. Over 3 months, there were 16 ovulatory cycles…

AdultOvulationmedicine.medical_specialtymedia_common.quotation_subjectmedicine.medical_treatmentDrug Administration ScheduleAnovulationInternal medicinemedicineHumansHypoglycemic AgentsInsulinOvulationMenstrual CycleMenstrual cyclemedia_commonbusiness.industryInsulinHyperandrogenismObstetrics and Gynecologymedicine.diseasePolycystic ovaryMetforminMetforminTreatment OutcomeEndocrinologyInfertilityFemaleHyperandrogenismLuteinizing hormonebusinessAnovulationPolycystic Ovary Syndromemedicine.drugAmerican Journal of Obstetrics and Gynecology
researchProduct

Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes

2009

Abstract OBJECTIVE: To evaluate the clinical and endocrine differences between main polycystic ovary syndrome (PCOS) phenotypes. DESIGN: To evaluate clinical and hormone parameters in a large group of consecutive women with PCOS diagnosed according Rotterdam criteria and divided according their phenotype. SETTING: University department of medicine. PATIENT(S): Three hundred eighty-two consecutive women with PCOS and 85 ovulatory controls. INTERVENTION(S): Evaluation of clinical and hormone parameters. MAIN OUTCOME MEASURE(S): Blood levels of gonadotropins, testosterone, sex-hormone-binding globulin, dehydroepiandrosterone sulfate, 17α-hydroxyprogesterone, progesterone, glucose, and insulin,…

AdultPCOS Lipids Insulin resistance Fertility Androgens Obesitymedicine.medical_specialtySettore MED/09 - Medicina Internaendocrine system diseasesEndocrine SystemSettore MED/13 - EndocrinologiaAnovulationYoung Adultchemistry.chemical_compoundDehydroepiandrosterone sulfateSex Hormone-Binding GlobulinInternal medicinePrevalencemedicineHumansTestosteroneRetrospective StudiesDehydroepiandrosterone SulfateFree androgen indexbusiness.industryHyperandrogenismObstetrics and GynecologyLuteinizing Hormonemedicine.diseaseSettore MED/40 - Ginecologia E OstetriciaPolycystic ovaryfemale genital diseases and pregnancy complicationsPhenotypeEndocrinologyReproductive MedicinechemistryCase-Control StudiesAndrogensFemaleFollicle Stimulating HormoneHyperandrogenismLuteinizing hormonebusinessPolycystic Ovary SyndromeHormoneFertility and Sterility
researchProduct

Autoimmune polyglanduläre Syndrome

2013

The autoimmune polyglandular syndrome (APS) is defined as the manifestation of at least two endocrine autoimmune diseases. In order to take the wide spectrum of components and the variations of the disease fully into account, APS is usually divided up into the rare juvenile type (APS I) and the more common adult type (APS II-IV). APS I is caused by a monogenetic mutation whereas APS II-IV has a multifactorial genesis with combination related subgroups. Early diagnosis, individual adjustment of therapy and screening of high risk patients in particular are regarded as clinically relevant. In addition to the patient's history, the diagnosis of APS encompasses serologic measurement of organ-spe…

AdultPediatricsmedicine.medical_specialtyEndometriosisPhysical examinationHashimoto DiseaseDiseaseDiagnosis DifferentialHypothyroidismPregnancyHumansMass ScreeningMedicineHashimoto DiseasePolyendocrinopathies AutoimmuneMass screeningAutoantibodiesmedicine.diagnostic_testbusiness.industryIncidence (epidemiology)AutoantibodyGeneral MedicineDiabetes GestationalFemaleDifferential diagnosisbusinessInfertility FemaleRare diseaseDMW - Deutsche Medizinische Wochenschrift
researchProduct